期刊文献+

Protective effect of telmisartan on rats with renal failure and its mechanism

Protective effect of telmisartan on rats with renal failure and its mechanism
下载PDF
导出
摘要 Objective:To study the protective effect of telmisartan on rats with renal failure and its mechanism.Methods:60 Wistar rats were chosen as study objective,and were divided into4 groups randomly:15 in group A(sham operation group).15 in group B(model group),15 in group C(telmisartan group) and 15 in group D(telmisartan+GW9962 group).The difference of survival rate,blood-urine biochemical indexes,renal pathological change,and the expression level of PPAR γ and nNOS were ompared.Results:After 12 weeks,the survival rate of group A was 93.33% (14/15),that of group B was 46.67% (7/15),that of group C was86.67% (13/15),that of group D was 60.00% (9/15),and the difference among 4 groups had statistical significance(P<0.05).After 1 week,the difference of Scr,that of BUN and that of24 h protein urine among 4 groups was not statistical significant(P>0.05);after 3 weeks,6 weeks and 12 weeks,these difference was statistical significant(P<0.05).The difference of blood-urine biochemical indexes,that of renal pathological change,and that of the expression level of PPAR γ and nNOS was statistical significant(P<0.05).Conclusions:Telmisartan has protective effect on renal failure caused by 5/6 nephrectomy,which might be relative to the expression level of PPAR γ and nNOS. Objective:To study the protective effect of telmisartan on rats with renal failure and its mechanism.Methods:60 Wistar rats were chosen as study objective,and were divided into4 groups randomly:15 in group A(sham operation group).15 in group B(model group),15 in group C(telmisartan group) and 15 in group D(telmisartan+GW9962 group).The difference of survival rate,blood-urine biochemical indexes,renal pathological change,and the expression level of PPAR γ and nNOS were ompared.Results:After 12 weeks,the survival rate of group A was 93.33% (14/15),that of group B was 46.67% (7/15),that of group C was86.67% (13/15),that of group D was 60.00% (9/15),and the difference among 4 groups had statistical significance(P&lt;0.05).After 1 week,the difference of Scr,that of BUN and that of24 h protein urine among 4 groups was not statistical significant(P&gt;0.05);after 3 weeks,6 weeks and 12 weeks,these difference was statistical significant(P&lt;0.05).The difference of blood-urine biochemical indexes,that of renal pathological change,and that of the expression level of PPAR γ and nNOS was statistical significant(P&lt;0.05).Conclusions:Telmisartan has protective effect on renal failure caused by 5/6 nephrectomy,which might be relative to the expression level of PPAR γ and nNOS.
出处 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2015年第6期497-500,共4页 亚太热带医药杂志(英文版)
基金 supported by Natural Science Foundation of Shandong Province(No.ZR2009CL018)
关键词 TELMISARTAN 5/6 NEPHRECTOMY RENAL FAILURE Telmisartan 5/6 nephrectomy Renal failure
  • 相关文献

参考文献4

二级参考文献23

  • 1张翥,苏克亮,黄颂敏,刘先蓉.肾小管间质纤维化的发生机理[J].国外医学(泌尿系统分册),2005,25(3):419-423. 被引量:14
  • 2杨林,段惠军.骨形成蛋白-7在肾纤维化中的作用[J].河北医科大学学报,2006,27(3):225-227. 被引量:12
  • 3Schomig M, Eisenhardt A, Ritz E. The microinflammatory state of uremia[J]. Blood Purif, 2000,18:327-332.
  • 4Perunicic-Pekovic G, Pljesa S, Rasic-Milutinovic Z, et al. Inflammatory cytokines and malnutrition as related to risk for cardiovascular disease in hemodialysis patients[J]. Can J Physiol Pharmacol, 2008,86:205-209.
  • 5Boenisch O, Ehmke KD, Heddergott A, et al. C-reactive- protein and cytokine plasma levels in hemodialysis patients [J]. J Nephrol, 2002,15:547-551.
  • 6Schouten WE, Grooteman MP, van Houte AJ, et al. Effects of dialyser and dialysate on the acute phase reaction in clinical bicarbonate dialysis[J]. Nephrol Dial Transplant, 2000,15:379-384.
  • 7Lamas JM, Alonso M, Sastre F, et al. Ultrapure dialysate and inflammatory response in haemodialysis evaluated by darbepoetin requirements--a randomized study[J]. Nephrol Dial Transplant, 2006,21:2851-2858.
  • 8Bommer J, Jaber BL. Ultrapure dialysate: facts and myths [J]. Semin Dial, 2006,19:115-119.
  • 9Shah SV, Baliga R, Rajapurkar M, et al. Oxidants in chronic kidney disease[J]. J Am Soc Nephrol, 2007,18:16-28.
  • 10Perez-Font On M, Cordido F, Rodriguez-Carmona A, et al. Plasma ghrelin levels in patients undergoing haemodialysis and peritoneal dialysis[J]. Nephrol Dial Transplant, 2004, 19:2095-2100.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部